Development of a model for the differential diagnosis of community-acquired bacterial pneumonia and viral lung injury in hospitalized adult patients
Authors:
Open Access
- 28 February 2024
- journal article
- research article
- Published by Publishing House OKI in Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice
- No. 4,p. 78-85
Abstract
Relevance. During and after the COVID-19 pandemic, viruses have become a more common cause of pulmonary infections in adults; therefore, the distinction between viral lung injury and community-acquired bacterial pneumonia is of increasing importance. Aim. Development of a model for differentiating community-acquired bacterial pneumonia and viral lung injury, including COVID-19. Materials and methods. This retrospective case–control study included 300 adult patients with viral lung injury and 100 adult patients with community-acquired bacterial pneumonia. Clinical, laboratory, and instrumental data were analyzed, significant factors were selected by which the samples differed, and a model was developed using logistic regression to distinguish between community-acquired bacterial pneumonia and viral lung damage, including COVID-19. Results. The developed model included the following parameters: total protein level, neutrophil/lymphocyte index, heart rate, unilateral infiltration on CT or chest x-ray, vasopressor prescription in the first 24 h of hospitalization, altered level of consciousness, chills, and fatigue. The model had the following characteristics: AUC = 0.94 (0.92–0.96), AUC_PR = 0.84 (0.76 to 0.92), prediction accuracy — 90%, sensitivity — 76%, specificity — 95%, positive predictive value — 83 %. Conclusion. The use of this model can facilitate the differential diagnosis of community-acquired bacterial pneumonia and viral lung injury, including COVID-19, in adults in general wards and intensive care units.Keywords
This publication has 18 references indexed in Scilit:
- Antibiotic resistance associated with the COVID-19 pandemic: a systematic review and meta-analysisClinical Microbiology and Infection, 2022
- Decreased number of inpatients with community-acquired pneumonia during the COVID-19 pandemic: A large multicenter study in JapanJournal of Infection and Chemotherapy, 2022
- Antimicrobial consumption in patients with COVID-19: a systematic review and meta-analysisExpert Review of Anti-infective Therapy, 2021
- Bacteraemic pneumococcal pneumonia and SARS-CoV-2 pneumonia: differences and similaritiesInternational Journal of Infectious Diseases, 2021
- Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysisClinical Microbiology and Infection, 2021
- Differential diagnosis and prospective grading of COVID-19 at the early stage with simple hematological and biochemical variablesDiagnostic Microbiology and Infectious Disease, 2021
- Laboratory indicators in COVID-19 and other pneumonias: Analysis for differential diagnosis and comparison of dynamic changes during 400-day follow-upComputational and Structural Biotechnology Journal, 2021
- Differential diagnosis between the coronavirus disease 2019 and Streptococcus pneumoniae pneumonia by thin-slice CT featuresClinical Imaging, 2021
- Comparison of clinical characteristics between coronavirus disease 2019 pneumonia and community-acquired pneumoniaCurrent Medical Research and Opinion, 2020
- Procalcitonin to Distinguish Viral From Bacterial Pneumonia: A Systematic Review and Meta-analysisClinical Infectious Diseases, 2019